News for WAT Stock

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio Waters Corporation to Present at the Jefferies Global Healthcare Conference Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results Waters Corporation Schedules First Quarter 2025 Earnings Conference Call Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC Waters Corporation to Present at the Leerink Partners Global Healthcare Conference Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results Waters ElectroForce Apex 1 Instrument Offers Increased Versatility, Simplicity, and Speed to Mechanical Testing of Advanced Polymer Materials Innovative Waters TGA Smart-Seal Pans Enable Lower Cost, More Efficient Benchtop Analysis of Atmosphere-Sensitive Materials Waters Corporation Schedules Fourth Quarter 2024 Earnings Conference Call Waters Corporation to Host Investor Day on March 5, 2025 Waters Corporation Named to Dow Jones Sustainability Index for the Fourth Consecutive Year Waters Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference Waters Highlights Continued Progress Towards Sustainability Commitments Waters Corporation to Present at the Evercore 2024 HealthCONx Conference Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK Waters New Software Delivers Lab-Centric Business Intelligence and Enables Confident Audit-Readiness Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call Waters Corporation Appoints Heather Knight to Board of Directors Waters Corporation (NYSE: WAT) Reports Second Quarter 2024 Financial Results Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs Waters Corporation Schedules Second Quarter 2024 Earnings Conference Call Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification Waters Corporation to Present at the Jefferies 2024 Healthcare Conference ObeEnd - Pioneering Drug-Free Weight Management Wristband Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument Waters Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns Waters Corporation Schedules First Quarter 2024 Earnings Conference Call Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS Accessory Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2023 Financial Results Waters Corporation Schedules Fourth Quarter 2023 Earnings Conference Call Waters Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference Waters Earns Sustainability Designation from My Green Lab for Xevo TQ Absolute System Waters Corporation Named to Dow Jones Sustainability Index for the Third Consecutive Year Waters Corporation Board of Directors Named 2024 Public Company Board of the Year by National Association of Corporate Directors New England Chapter NACD New England honors Waters Corp. and Devoted Health as Public and Private Company “Boards of the Year” Waters Corporation Opens New State-of-the-Art Global Capability Center in Bengaluru, India Waters Earns Top Score in Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index Waters Corporation to Present at the Evercore ISI HealthCONx 2023 Health Care Conference WATERS 2023 ESG REPORT HIGHLIGHTS CONTINUED PROGRESS TOWARDS SUSTAINABILITY COMMITMENTS Waters Corporation (NYSE: WAT) Reports Third Quarter 2023 Financial Results Waters Corporation Announces Business Unit Leadership Transition Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits Waters Corporation Schedules Third Quarter 2023 Earnings Conference Call Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023 Waters Corporation (NYSE: WAT) Reports Second Quarter 2023 Financial Results Waters Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications Waters Corporation Schedules Second Quarter 2023 Earnings Conference Call Waters Corporation and Princeton University Announce Multi-Year Research Collaboration Waters Boosts Resolution and Triples Scan Speed of SELECT SERIES MRT for Metabolomics and MS Imaging Waters Takes Targeted, Quantitative Imaging to the Next Level with New DESI Source for the Xevo TQ Absolute System Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing Waters Corporation to Present at the Jefferies 2023 Healthcare Conference Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology Waters Corporation (NYSE: WAT) Reports First Quarter 2023 Financial Results Waters Corporation Schedules First Quarter 2023 Earnings Conference Call Waters Launches its Most Sensitive and Compact Clinical IVD System with Xevo TQ Absolute IVD Mass Spectrometer Waters Corporation Appoints Richard Fearon to Board of Directors Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors Waters’ New Battery Cycler Microcalorimeter Solution Accelerates Real-World Testing from Months to Weeks Waters Corporation Listed as No. 5 on Barron's 100 Most Sustainable Companies 2023 List Waters Corporation Presentation at the Cowen 43rd Annual Health Care Conference to be Webcast Live Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2022 Financial Results Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader New waters_connect System Monitoring Software Maximizes Productivity with Real-Time, Cloud-Native Lab Management Waters Corporation Schedules Fourth Quarter 2022 Earnings Conference Call Waters Corporation Recognized for its Award-winning Products, Outstanding Leadership, and ESG Progress Waters Corporation Presentation at the 41st Annual J.P. Morgan Healthcare Conference to Be Audio Webcast Live Waters Corporation Named to Dow Jones Sustainability Index for Second Consecutive Year Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors Waters Introduces New PFAS Quantitation Workflow Enabled by Enhancements to waters_connect Informatics Platform Waters Corporation Presentation at the Evercore ISI HealthconX 2022 Virtual Health Care Conference to Be Webcast Live Waters Highlights ESG Progress and New Commitments in its 2022 Report Waters Corporation (NYSE: WAT) Reports Third Quarter 2022 Financial Results Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford Waters Corporation Schedules Third Quarter 2022 Earnings Conference Call Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis Waters Announces Bay State’s First LEED-Certified Chemical Manufacturing Facility Waters Corporation Presentation at the Bank of America 2022 Global Health Care Conference Waters Corporation (NYSE: WAT) Reports Second Quarter 2022 Financial Results Waters Collaborates with Leading Researchers and Industry Partners to Advance the Science of Alternative Proteins Waters Corporation Schedules Second Quarter 2022 Earnings Conference Call Waters and BioInfra Establish the ASEAN Academy for Bioanalysis to Promote Analytical Skills Development Waters Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development Waters Corporation Presentation at the Jefferies 2022 Global Health Care Conference Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results Waters Corporation to Host Investor Day Waters Corporation Q1 2022 Financial Results Webcast Invitation Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer Waters Introduces Faster, Reliable and Automated Solution for Mass and Purity Analysis of Biomolecules Waters Corporation Presentation at the Cowen 42nd Annual Health Care Conference Waters Corporation Virtual Fireside Chat at Citi’s 2022 Virtual Healthcare Conference (including: Services, MedTech, Life Science Tools & HCIT) Waters Acquires Charge Detection Mass Spectrometry Technology to Broaden its Application in Cell and Gene Therapy Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2021 Financial Results Waters Earns Top Score in Human Rights Campaign Foundation’s 2022 Corporate Equality Index U.S. Food and Drug Administration Expands Deployment of Waters Corporation Software to Support its Medical Products Testing Labs Waters Corporation Q4 2021 Financial Results Webcast Invitation Waters Accelerates Quantitative Mass Spectrometry With New Application on waters_connect Informatics Platform Waters Corporation Presentation at the 40th Annual J.P. Morgan Healthcare Conference to be Webcast Live Waters Corporation Presentation at the Evercore ISI HealthCONx 2021 Virtual Health Care Conference to Be Webcast Live Waters’ 2021 Sustainability Report Highlights Progress on ESG Initiatives and Response to COVID-19 Waters Corporation (NYSE: WAT) Reports Third Quarter 2021 Financial Results Waters and Sartorius Partner to Help Bioprocess Scientists Accelerate Clone Selection and Process Development Waters and University of Delaware Announce Bioprocessing Innovation Partnership, Plan 2022 Opening of Immerse Delaware Lab Waters Corporation Q3 2021 Financial Results Webcast Invitation Waters Corporation Appoints John M. Ballbach to Board of Directors Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals Waters to Present at the Bank of America Global Healthcare Conference 2021 Waters to Participate in a Virtual Fireside Chat at Morgan Stanley's 19th Annual Global Healthcare Conference Waters Corporation (NYSE: WAT) Reports Second Quarter 2021 Financial Results Waters Corporation Q2 2021 Financial Results Webcast Invitation TA Instruments Helps Laboratories Automate Thermal Analysis Workflows with New TRIOS AutoPilot Software Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute Waters Corporation Appoints Wei Jiang to Board of Directors Waters Arc Premier System Delivers Increased Precision and Certainty in Chromatographic Results Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases Waters Corporation Celebrates the Life and Legacy of its Founder, Jim Waters Waters Corporation (NYSE: WAT) Reports First Quarter 2021 Financial Results Waters Corporation Presentation at the Bank of America Securities 2021 Virtual Health Care Conference to Be Audio Webcast Live Waters Corporation Continues Transformation with Planned Leadership Transitions Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization Waters Corporation Q1 2021 Financial Results Webcast Invitation Waters Peptide Multi-Attribute Method for BioAccord System Boosts Innovator and Biosimilar Drug Development and Commercialization Waters Improves Ease and Reliability of Small Molecule Analysis with ACQUITY RDa Detector Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link Waters Corporation Presentation at the 41st Annual Cowen Healthcare Conference to Be Audio Webcast Live Waters Redefines Laboratory Science with New ACQUITY PREMIER Liquid Chromatography Solution Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2020 Financial Results Waters Otto SPEcialist Positive Pressure Manifold Improves Reproducibility and Reliability of Solid-Phase Extraction (SPE) Waters Corporation Q4 2020 Financial Results Webcast Invitation Waters APGC-MS/MS System Accepted for Advanced Dioxin and Furan Analysis Following USEPA Approval of SGS AXYS Method 16130 Waters Corporation Presentation at the 39th Annual J.P. Morgan Healthcare Conference to Be Audio Webcast Live Waters Corporation Appoints Pearl S. Huang to Board of Directors Waters Collaborates with Dr. Sunghwan Kim of Kyungpook National University to Advance Precision Analysis of Complex Chemical Compounds Waters Corporation Announces CFO Transition Waters Corporation (NYSE: WAT) Reports Third Quarter 2020 Financial Results Andrew Alliance Earns Acclaim from Frost & Sullivan for Its Innovative Pipetting Robot, Andrew+ Waters ACQUITY PREMIER Columns Set a New Standard of Performance for Chromatographic Analyses Waters Corporation Q3 2020 Financial Results Webcast Invitation